Nothing Special   »   [go: up one dir, main page]

NO20065115L - Cellulaer tillatende faktor for virus, og anvendelse derav - Google Patents

Cellulaer tillatende faktor for virus, og anvendelse derav

Info

Publication number
NO20065115L
NO20065115L NO20065115A NO20065115A NO20065115L NO 20065115 L NO20065115 L NO 20065115L NO 20065115 A NO20065115 A NO 20065115A NO 20065115 A NO20065115 A NO 20065115A NO 20065115 L NO20065115 L NO 20065115L
Authority
NO
Norway
Prior art keywords
viruses
cellular
permitting
factor
permitting factor
Prior art date
Application number
NO20065115A
Other languages
English (en)
Other versions
NO341211B1 (no
Inventor
Siao-Kun Wan Welch
Jay Gregory Calvert
Shelly Lynn Shields
David Ewell Slade
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of NO20065115L publication Critical patent/NO20065115L/no
Publication of NO341211B1 publication Critical patent/NO341211B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0686—Kidney cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0688—Cells from the lungs or the respiratory tract
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/12011—Asfarviridae
    • C12N2710/12051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer fremgangsmåter og sammensetninger vedrørende generering av vertsceller som tillater virusvekst, spesielt reproduktivt svinerespiratorisk syndrom (PRRS) virus.
NO20065115A 2004-04-23 2006-11-06 In vitro fremgangsmåte for å fremme infeksjon i en virveldyrcelle med PRRSV og en fremgangsmåte for å måle tilbøyeligheten en testcellelinje har for å tillate PRRSV-infeksjon NO341211B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56521404P 2004-04-23 2004-04-23
US63473604P 2004-12-09 2004-12-09
PCT/US2005/011502 WO2005107796A2 (en) 2004-04-23 2005-04-05 Cellular permissivity factor for viruses, and uses thereof

Publications (2)

Publication Number Publication Date
NO20065115L true NO20065115L (no) 2006-11-06
NO341211B1 NO341211B1 (no) 2017-09-11

Family

ID=35320736

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065115A NO341211B1 (no) 2004-04-23 2006-11-06 In vitro fremgangsmåte for å fremme infeksjon i en virveldyrcelle med PRRSV og en fremgangsmåte for å måle tilbøyeligheten en testcellelinje har for å tillate PRRSV-infeksjon

Country Status (22)

Country Link
US (4) US7754464B2 (no)
EP (2) EP1742658B1 (no)
JP (2) JP5273642B2 (no)
CN (1) CN102220289B (no)
AR (3) AR049033A1 (no)
AU (2) AU2005240002B2 (no)
BR (1) BRPI0508928B1 (no)
CA (1) CA2564769C (no)
CL (1) CL2008002323A1 (no)
DK (1) DK1742658T3 (no)
EA (1) EA013071B1 (no)
ES (2) ES2570665T3 (no)
HK (1) HK1109065A1 (no)
IL (1) IL178160A0 (no)
MA (1) MA28544B1 (no)
MX (1) MXPA06012216A (no)
NO (1) NO341211B1 (no)
NZ (1) NZ550145A (no)
PL (1) PL1742658T3 (no)
TW (2) TWI354025B (no)
UY (1) UY28867A1 (no)
WO (1) WO2005107796A2 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0508928B1 (pt) * 2004-04-23 2015-10-06 Pah P & U Llc Processo de falicitação da infecção de uma célula de vertebrado por PRRSV e para medir a propensão de uma linhagem de células teste à referida infecção
CA2675139C (en) 2007-01-12 2019-02-19 The Board Of Trustees Of The University Of Illinois Non-simian cells for growth of porcine reproductive and respiratory syndrome (prrs) virus
US8420373B2 (en) * 2007-07-27 2013-04-16 Universiteit Gent Permissive cells and uses thereof
UA108902C2 (uk) * 2010-11-10 2015-06-25 Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування
KR20150020209A (ko) 2012-05-17 2015-02-25 조에티스 엘엘씨 이유 전 돼지 생식기 호흡기 증후군(prrs) 바이러스에 대한 효과적인 백신접종
CN103525766B (zh) * 2013-03-24 2015-06-17 西北农林科技大学 一种猪肾细胞系及其应用
GB201313235D0 (en) 2013-07-24 2013-09-04 Univ Edinburgh Antiviral Compositions Methods and Animals
CN104459160A (zh) * 2014-12-30 2015-03-25 洛阳普莱柯万泰生物技术有限公司 试剂盒及其制备方法和使用方法
GB201617559D0 (en) 2016-10-17 2016-11-30 University Court Of The University Of Edinburgh The Swine comprising modified cd163 and associated methods
KR102602018B1 (ko) * 2016-12-14 2023-11-15 조에티스 서비시즈 엘엘씨 젖떼기 전, 유럽의 돼지 생식기 및 호흡기 증후군 (prrs) 균주 바이러스에 대한 효과적인 백신접종
CN108103099B (zh) * 2017-12-18 2022-03-04 中山大学 一种抗蓝耳病Marc-145细胞系及其制备方法和应用
CN108893450B (zh) * 2018-08-13 2022-04-19 江苏省农业科学院 先天性免疫系统重构的bhk21细胞群及其细胞克隆增毒应用
CN111996213A (zh) * 2020-02-06 2020-11-27 广西大学 猪繁殖与呼吸综合征病毒双荧光标记基因重组毒株的构建方法
KR102254246B1 (ko) * 2020-03-23 2021-05-20 큐벳 주식회사 항-cd163 항체 또는 이의 항원 결합 단편을 인코딩하는 핵산 분자 및 이를 포함하는 아데노바이러스 벡터, 및 이의 아프리카 돼지열병의 예방 또는 치료용도
US11796548B2 (en) * 2020-04-22 2023-10-24 The United States Of America, As Represented By The Secretary Of Agriculture Continuous stable cell line for identification of infectious African swine fever virus in clinical samples
WO2024123640A1 (en) 2022-12-06 2024-06-13 Zoetis Services Llc Methods and compositions for vaccinating piglets against prrs-1 virus

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622871A (en) 1987-04-27 1997-04-22 Unilever Patent Holdings B.V. Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4517288A (en) 1981-01-23 1985-05-14 American Hospital Supply Corp. Solid phase system for ligand assay
CA1291031C (en) 1985-12-23 1991-10-22 Nikolaas C.J. De Jaeger Method for the detection of specific binding agents and their correspondingbindable substances
CA1303983C (en) 1987-03-27 1992-06-23 Robert W. Rosenstein Solid phase assay
AU643427B2 (en) 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
US5118937A (en) 1989-08-22 1992-06-02 Finnigan Mat Gmbh Process and device for the laser desorption of an analyte molecular ions, especially of biomolecules
BR9007937A (pt) 1989-12-22 1992-11-17 Applied Research Systems Modificacao da expressao de gene endogeno com elemento regulador
AU651596B2 (en) 1990-06-05 1994-07-28 Immunex Corporation Type II interleukin-1 receptors
WO1992020808A1 (en) 1991-05-15 1992-11-26 Cell Genesys, Inc. Genomic modifications with homologous dna targeting
US5846805A (en) 1991-08-26 1998-12-08 Boehringer Ingelheim Animal Health, Inc. Culture of swine infertility and respiratory syndrome virus in simian cells
US5514545A (en) 1992-06-11 1996-05-07 Trustees Of The University Of Pennsylvania Method for characterizing single cells based on RNA amplification for diagnostics and therapeutics
TW402639B (en) 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
AU676582B2 (en) 1993-05-28 1997-03-13 Baylor College Of Medicine Method and apparatus for desorption and ionization of analytes
ATE206455T1 (de) * 1994-04-11 2001-10-15 Akzo Nobel Nv Europäische vakzinstämme des fortplanzungs- atmungs-syndromsvirus des schweins
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
WO1998035023A1 (en) * 1997-02-07 1998-08-13 Origen, Inc. Method for growing porcine reproductive and respiratory syndrome virus for use as vaccines and diagnostic assays
US6740490B2 (en) * 2001-01-29 2004-05-25 Kansas State University Research Foundation Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding
CA2453115C (en) 2001-07-24 2012-04-03 Akzo Nobel, N.V. Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
WO2003100419A1 (en) * 2002-05-27 2003-12-04 Bioceros B.V. Methods for using the cd163 pathway for modulating an immune response
BRPI0508928B1 (pt) * 2004-04-23 2015-10-06 Pah P & U Llc Processo de falicitação da infecção de uma célula de vertebrado por PRRSV e para medir a propensão de uma linhagem de células teste à referida infecção

Also Published As

Publication number Publication date
EP2520310B1 (en) 2016-03-30
CN102220289B (zh) 2014-05-21
EA013071B1 (ru) 2010-02-26
TW201134944A (en) 2011-10-16
US8486685B2 (en) 2013-07-16
EP1742658A2 (en) 2007-01-17
AU2005240002A1 (en) 2005-11-17
EP2520310A1 (en) 2012-11-07
AR049033A1 (es) 2006-06-21
MXPA06012216A (es) 2007-01-17
AU2005240002B2 (en) 2009-06-18
CN102220289A (zh) 2011-10-19
PL1742658T3 (pl) 2015-05-29
IL178160A0 (en) 2006-12-31
CL2008002323A1 (es) 2008-12-19
NO341211B1 (no) 2017-09-11
MA28544B1 (fr) 2007-04-03
NZ550145A (en) 2009-07-31
EP1742658A4 (en) 2007-11-28
US7754464B2 (en) 2010-07-13
US20050271685A1 (en) 2005-12-08
US8058050B2 (en) 2011-11-15
JP2007533321A (ja) 2007-11-22
HK1109065A1 (en) 2008-05-30
US20140141492A1 (en) 2014-05-22
WO2005107796A2 (en) 2005-11-17
DK1742658T3 (en) 2015-01-19
TWI438278B (zh) 2014-05-21
WO2005107796A3 (en) 2007-04-12
AU2009202410A1 (en) 2009-07-09
JP5600340B2 (ja) 2014-10-01
ES2530694T3 (es) 2015-03-04
TWI354025B (en) 2011-12-11
EP1742658B1 (en) 2014-12-24
US20100273238A1 (en) 2010-10-28
CA2564769A1 (en) 2005-11-17
AR084530A2 (es) 2013-05-22
JP5273642B2 (ja) 2013-08-28
CA2564769C (en) 2013-12-17
UY28867A1 (es) 2005-11-30
ES2570665T3 (es) 2016-05-19
US9102912B2 (en) 2015-08-11
TW200604343A (en) 2006-02-01
BRPI0508928B1 (pt) 2015-10-06
JP2013078324A (ja) 2013-05-02
AR084529A2 (es) 2013-05-22
EA200601677A1 (ru) 2007-10-26
US20120015425A1 (en) 2012-01-19
BRPI0508928A (pt) 2007-08-14

Similar Documents

Publication Publication Date Title
NO20065115L (no) Cellulaer tillatende faktor for virus, og anvendelse derav
ZA200606620B (en) Methods of modulating IL-23 activity ; related reagents
TW200732349A (en) Anti-OX40L antibodies and methods using same
DE602006017725D1 (de) Nukleinsäuren, kodierend für impfstoffe gegen den reproduktiven und respiratorischen syndrom virus (prrsv)
RS20060320A (en) Substituted indazole-o-glucosides
NO20080246L (no) Anti-IGF1R-antistofformuleringer
UA86042C2 (en) Substituted indazole-o-glucosides
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
NO20080505L (no) Ionisk vaeske rekonstituerte cellulosekompositter som faste baerematriser
ATE432067T1 (de) Embolie-teilchen
EA200701918A1 (ru) Белок липокалин
EA200900781A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды
NO20073065L (no) Injiserbare nanopartikulaere olanzapinformuleringer
TW200745035A (en) Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
DK1682530T3 (da) Pyrrolsubstituerede indoler som inhibitorer af PAI-1
EA200901109A1 (ru) Применение n-фениламидинов в качестве гербицидов
EA200700904A1 (ru) Вакцины против вируса японского энцефалита и вируса западного нила
TW200641126A (en) N protein mutants of porcine reproductive and respiratory syndrome virus
EA200900267A1 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ И СТЕРОИДОВ
NO20083593L (no) Anti-EphrinB2-antistoffer og fremgangsmater for anvendelse av disse
EA200801414A1 (ru) Кальцилитические соединения
EP1794329A4 (en) ISOLATES OF PORCINE RESPIRATORY DYSGENESIS SYNDROME (SDRP), AND METHODS OF USE
DE602005011780D1 (de) Triazinderivate mit carbamatfunktion
EA200600404A1 (ru) Пероральные препаративные формы кладрибина

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ZOETIS P&U LLC, US

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ZOETIS SERVICES LLC, US

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ZOETIS SERVICES LLC, US